Radiotherapy has played a limited role in the treatment of hepatocellular carcinoma (HCC) due to the risk of tumor radioresistance. A previous study in our lab confirmed that CD147 interacts with integrin β1 and plays an important role in modulating the malignant properties of HCC cells. In this study, we further evaluated the role of CD147 in the radioresistance of HCC and as a potential target for improving radiosensitivity. Upon irradiation, the colony formation, apoptosis, cell 
Introduction
As the fifth most common malignant tumor, hepatocellular carcinoma (HCC) carries a poor survival rate. Most patients are not surgical candidates at the time of diagnosis because of vascular invasion, multifocality, and large tumor size, and liver shortage has been the rate-limiting step in the expansion of hepatic transplantation for HCC patients (1, 2) . Therefore, nonresectional therapies, including radiotherapy combined with other locoregional treatments, have been introduced to improve survival in patients with advanced HCC (3) .
Radiotherapy has played a limited role in the treatment of HCC due to the low tolerance of the liver and the risk of tumor radioresistance (4) . Despite the response of HCC to stereotactic body radiation therapy (SBRT) has been described for the past few years, and the fact that radiation can be delivered to tumors while avoiding damage to normal sensitive organs (5) , the existence of radioresistant cells in HCC is remains an important reason for the local failure of radiotherapy (6, 7) . Thus, understanding the mechanisms underlying radioresistance may provide an opportunity to develop more effective therapies.
As critical cell adhesion molecules that mediate the crosstalk between tumor cells and the signaling from the extracellular space into the cell, integrins participate in cell survival, invasion, metastasis, and some other malignant properties (8) (9) (10) (11) .
Activation of the integrin pathway contributes to tumor radioresistance, and downstream focal adhesion kinase (FAK) and phosphatidylinositol-3-kinase (PI3-K)/protein kinase B (Akt) signaling have been linked to decreased radiation responsiveness in various malignant tumors, including head and neck cancer, pancreatic cancer, breast cancer, nasopharyngeal carcinoma, and glioblastoma (12) (13) (14) (15) (16) (17) . ionizing radiation represents a prerequisite for metastasis (18) . FAK knockdown enhanced the radiosensitivity of HNSCC cells, and the downstream molecules of FAK, including paxillin, Akt1, and ERK1/2, were substantially dephosphorylated under FAK depletion (19) . Irradiation enhances the invasiveness of HCC cells, which correlated with elevated MMP-9 expression and activated PI3K/Akt/NF-κB signaling (7) . Although several lines of evidence have suggested the contribution of the integrin pathway to radioresistance, little is known about its role in the radioresistance of HCC.
As a member of the immunoglobulin superfamily, CD147 is overexpressed in a number of epithelial cell-derived carcinomas and is associated with tumor development (20) (21) (22) (23) . In previous studies, we demonstrated that the interaction of HAb18G/CD147 with integrin β1 activates the downstream FAK/PI3K-Akt signaling pathway, subsequently enhancing the malignant properties and inhibiting the chemosensitivity of HCC cells (24, 25) . Knocking out HAb18G/CD147 in HCC cells has been proven to result in p53 up-regulation (26) , and the functional p53 pathway could induce G0/G1 arrest or apoptosis upon radiation treatment (27) . Given the correlations between apoptosis and radiosensitivity, we hypothesized that HAb18G/CD147 may enhance the radioresistance of HCC cells by interacting with integrin β1.
In this study, we demonstrated that HAb18G/CD147 contributes to the radioresistance of HCC cells. HAb18G/CD147 knockout and antibody blockade significantly enhanced radiosensitivity of HCC cells, and markedly attenuated irradiation-induced migration and invasion, as well as the tumor growth potential and metastatic potential. HAb18G/CD147 contributes to the integrin β1 inside-out pathway and activates integrin β1. Meanwhile, HAb18G/CD147 interacts with 
Materials and Methods

Cell culture
Zinc finger nuclease technology was used to knock out HAb18G/CD147 in HCC SMMC-7721 cells, and the engineered cell line was named as K7721 (26) . CD147 was stably knocked down in SMMC-7721 and HepG2 cells by shRNA, and the cell lines were named as sh7721 (24) and shHepG2, respectively. The HCC cell lines SMMC-7721, K7721, sh7721, HepG2, shHepG2 and Huh7 were cultured in DMEM supplemented with 10% fetal calf serum and 1% penicillin/streptomycin. SMMC-7721 and HepG2 cells were obtained from the Institute of Cell Biology, Academic Sinica, Shanghai, China, and Huh7 cells were obtained from the JCRB Cell Bank, Japan. All cells have been authenticated by short tandem repeat profiling.
RNA extraction, Reverse Transcription and RT-qPCR
RNA extraction, Reverse Transcription and RT-qPCR were performed as described previously (24) . The primers used are listed in Supplementary Methods.
Irradiation procedure for cultured cells
Cells were irradiated using an X-ray (Elekta Precise Linac, the PLA 323 Hospital, Xi'an, China) or 60 Co γ-ray facility (Radiation Center of Fourth Military Medical University, Xi'an, China) at room temperature. The doses applied in the experiments varied from 0 Gy to 8 Gy.
Invasion assay, wound healing assay and colony-forming assay
Invasion assay, colony-forming assay and wound healing assay were performed 
Flow cytometric analysis
Flow cytometry was used to identify cell cycle distribution and cell apoptosis and to detect CD147 and active integrin β1 expression in hepatoma cells. Detailed information is described in the Supplementary Methods. 7721-GFP and K7721-GFP cells were irradiated with X-rays at 4 Gy. A total of 24 mice were randomized into four groups (7721-GFP group, 7721-GFP+X-ray group, K7721-GFP group, K7721-GFP+X-ray group). The methodology used to create the orthotopic HCC model was previously described (24) . 
Statistical Analysis
Unless otherwise stated, data were obtained from three independent experiments.
The results were expressed as the mean ± standard deviation. 
Results
Effects of X-ray irradiation on the survival and apoptosis of HCC cells with different HAb18G/CD147 levels
Three HCC cell lines, HepG2, Huh7 and SMMC-7721, were exposed to X-ray irradiation at doses varying from 0 Gy to 8 Gy. Cell survival was determined by a standard clonogenic assay ( Fig. 1A and B) , and cell death was analyzed with Annexin V-FITC/PI staining ( 
X-ray radiation induced the up-regulation of HAb18G/CD147 and molecules related to angiogenesis and metastasis
As shown in Fig. 1E , the mRNA levels of HAb18G/CD147, VEGF and EGF were significantly increased in HepG2, Huh7 and SMMC-7721 cells after exposure to low-dose X-ray radiation. The dose-dependent increase in expression levels of these molecules was already apparent after 3 days and reached a maximum after 9 days. (Fig. 1G and H) , which may promote tumor progression under low-dose radiation. These results demonstrate a potential role of upregulated HAb18G/CD147 in processes contributing to HCC radioresistance.
CD147 deletion enhanced the radiosensitivity of HCC cells
To further investigate the role of HAb18G/CD147 in radioresistance, CD147 was 
CD147 deletion attenuates the irradiation-enhanced invasion and migration of HCC cells
To determine the effects of irradiation on HCC cell motility and invasion, SMMC-7721 and K7721 cells were treated with or without 4 Gy X-ray radiation. As shown in Fig. 3 , scratch wound closure of SMMC-7721 cells was enhanced after X-ray radiation treatment (Fig. 3A and B) , and the numbers of cells transferred to the lower surface in the transwell chamber were increased (Fig. 3C and D) . In K7721 cells, radiation-enhanced migration and invasion potentials were markedly inhibited Fig. 3) . The results demonstrate that the deletion of HAb18G/CD147 attenuated irradiation-enhanced invasion and migration, which may have resulted from reduced expression of MMPs.
CD147 deletion enhanced the radiosensitive effect on tumorigenesis of HCC cells in nude mice
To investigate the ability of HCC cells to initiate tumor formation after irradiation, we 
CD147 deletion attenuates the intrahepatic growth and metastatic potential of irradiated HCC cells in nude mice
To test the metastatic potential of HCC cells post radiation, 7721-GFP cells and K7721-GFP cells were subjected to orthotopic implantation 48 h after radiation exposure. Tumor growth was determined by GFP imaging, and representative images of each group are shown in Fig. 4D . The in situ tumor sizes showed a slight but not significant difference between the non-irradiated 7721-GFP group and the non-irradiated K7721-GFP group, whereas tumor growth was significantly inhibited in the irradiated K7721-GFP group (Fig. 4E) Fig. S1 ).
These results show that the deletion of HAb18G/CD147 attenuated the promotion of hepatic metastasis induced by irradiation.
HcHAb18 increased the radiosensitivity of HCC cells in an orthotopic intrahepatic model
To block CD147 in the membranes of HCC cells, we pretreated SMMC-7721 cells with a humanized modified chimeric anti-HAb18G/CD147 antibody, HcHAb18 (Metuzumab). Because both X-knife and γ-knife therapies have been developed to treat liver cancer patients in China, we combined γ-knife therapy with HcHAb18 for the treatment of HCC in the orthotopic intrahepatic mouse model. After exposure to γ-ray irradiation at doses varying from 0 Gy to 8 Gy, the survival fractions of cells were determined (Fig. 5A and B) . Our results showed that HcHAb18 treatment enhanced the radiosensitivity of HCC cells in a dose-dependent manner. Compared with treatment with γ-ray irradiation or HcHAb18 alone, the combination of γ-ray irradiation and HcHAb18 resulted in a significant decrease in the survival rate ( and radiotherapy compared with those treated with radiation or high-dose HcHAb18 alone. There were marked variations in the survival of mice between all of the groups (Fig. 5F, P=0 .0027). In comparison with both the saline-treated control group with γ-ray radiotherapy and the 50 mg/kg HcHAb18-treated group, mice treated with a combination of 50 mg/kg HcHAb18 and radiotherapy showed prolonged survival (Fig.   5F ). These results suggest that the antibody blockade of CD147 markedly inhibited the tumor growth and intrahepatic metastasis of HCC cells induced by radiation and improved the therapeutic effect of radiotherapy.
Integrin signaling is involved in the radioresistance of HCC cells induced by
HAb18G/CD147
To investigate the role of the HAb18G/CD147-integrin interaction in the radioresistance of HCC cells, we examined HAb18G/CD147 expression and integrin activation by flow cytometry. As shown in Fig. 6A Immunoblotting showed that CD147 knockdown resulted in decreased levels of calpain and cleaved talin (Fig. 6B) . These results demonstrated a crucial role of The expression levels of both p-FAK (Tyr397) and p-Akt (Ser473) were significantly diminished in K7721 cells compared with those in SMMC-7721 cells (Fig. 6D) . (Fig. 6D) .
To explore the role of the FAK-PI3K/Akt pathway in radioresistant HCC cells, we tested the abilities of FAK and PI3K inhibitors to increase the radiosensitivity of SMMC-7721 cells. Signaling inhibition by these inhibitors was confirmed, as shown by decreased FAK and Akt phosphorylation (Fig 6D) . Radiation caused early apoptosis at 8.85%, whereas combined treatment of the cells with a signaling inhibitor and irradiation significantly enhanced the induction of apoptosis by 4.37 times and 3.68 times for the FAK inhibitor and PI3K inhibitor, respectively (Fig. 6E) . We also observed enhancing effects of the integrin blocking antibody on the levels of apoptosis, with or without irradiation (Fig. 6E) 
may be due to the cleavage of talin and the activation of integrin inside-out signaling (33) (34) . In this study, CD147 deletion resulted in decreased levels of active integrin β1, calpain and cleaved talin, and suppressing calpain and talin expression resulted in dramatically reduced FAK phosphorylation. These results suggest a crucial role of CD147 in mediating integrin inside-out signaling.
FAK and PI3K/Akt play important roles downstream of the outside-in integrin signaling pathway. FAK signaling contributes to the proliferation and survival of cells and is thus linked to the cell adhesion-mediated radioresistance of cancer cells (35) .
FAK can inhibit p53 expression (36) (37) , and WT p53 protein has been proven to facilitate radiation-induced apoptosis (27) . PI3K/Akt signaling is well characterized with respect to promoting cell survival and suppressing apoptosis. There is evidence that PI3K pathway inhibition enhances radiation-induced anti-angiogenesis and increases tumor radiosensitivity by normalizing the tumor vasculature (38) (39) inside-out signaling and forming a positive feedback loop (Fig. 6F) . The loss of WT p53 protein in SMMC-7721 cells may also contribute to the decreased radiosensitivity (Fig. 6F) . assay was performed, and phase-contrast images were taken (E, ×400; F, ×200).
Plating efficiency and survival curves of cells exposed to increased irradiation were shown. 
